These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12397766)

  • 41. [Use of beta-interferon in the treatment of multiple sclerosis: high-rate injectable dose therapy].
    Demina TL; Khachanova NV; Davydovskaia MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(5):76-9. PubMed ID: 15952547
    [No Abstract]   [Full Text] [Related]  

  • 42. Identity of interferon-beta1a product in multiple sclerosis study.
    Wolf WW
    Ann Neurol; 1997 Apr; 41(4):560. PubMed ID: 9124816
    [No Abstract]   [Full Text] [Related]  

  • 43. Recurrent orbital inflammation in a patient with multiple sclerosis treated with interferon-beta.
    Spierer O; Leibovitch I
    Clin Exp Ophthalmol; 2011 Nov; 39(8):835-7. PubMed ID: 22050569
    [No Abstract]   [Full Text] [Related]  

  • 44. [Chronic viral hepatitis C in patient with Hand-Schüller-Christian disease].
    Łapiński TW; Grzeszczuk A
    Pol Merkur Lekarski; 2001 Jul; 11(61):49-51. PubMed ID: 11579831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Case of chronic type C hepatitis complicated with idiopathic thrombocytopenic purpura that was successfully treated by interferon therapy].
    Karasawa T; Togashi H; Tajima K; Suzuki A; Onodera S; Haga H; Ishii R; Misawa K; Sanjo M; Okumoto K; Nishise Y; Ito J; Sugahara K; Saito K; Saito T; Kawata S
    Nihon Shokakibyo Gakkai Zasshi; 2009 Mar; 106(3):405-10. PubMed ID: 19262055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful intravenous interferon-beta treatment of chronic hepatitis C in a patient with Bernard-Soulier syndrome.
    Suzuki K; Hayashi T; Akiba J; Yoshino M; Tajima K; Satoh S; Shinzawa H; Kato T
    Thromb Res; 2000 Nov; 100(3):149-52. PubMed ID: 11108901
    [No Abstract]   [Full Text] [Related]  

  • 47. [Prescriptions from outside of Quebec: how to check it out].
    Brodeur J
    Perspect Infirm; 2010; 7(5):35. PubMed ID: 21744632
    [No Abstract]   [Full Text] [Related]  

  • 48. An Autopsy Case of Fulminant Hepatitis in a Patient with Multiple Sclerosis Treated by Interferon-Beta-1a.
    Yamazaki Y; Suzuki A; Hirayanagi K; Tsukagoshi Y; Uehara R; Horiguchi K; Ohyama T; Tomaru T; Horiguchi N; Nobusawa S; Ikota H; Sato K; Kakizaki S; Kusano M; Ikeda Y; Yokoo H; Yamada M
    Intern Med; 2017; 56(14):1897-1901. PubMed ID: 28717089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Co-existence of tumefactive MS and hepatitis C: A need for further screening and new therapeutic challenge.
    McGee J; Minagar A
    J Neurol Sci; 2015 Feb; 349(1-2):1-2. PubMed ID: 25592413
    [No Abstract]   [Full Text] [Related]  

  • 50. Interferon-beta1a-induced juvenile chronic arthritis in a genetically predisposed young patient with multiple sclerosis: comment on the case report by Levesque et al.
    Russo R; Tenembaum S; Moreno MJ; Battagliotti C
    Arthritis Rheum; 2000 May; 43(5):1190. PubMed ID: 10817580
    [No Abstract]   [Full Text] [Related]  

  • 51. Malignant melanoma in a multiple sclerosis patient with persistent neutralizing antibodies to interferon-beta.
    Gibbs E; Tremlett H; Ball N; Hashimoto S
    Eur J Neurol; 2008 Jan; 15(1):e4. PubMed ID: 18171383
    [No Abstract]   [Full Text] [Related]  

  • 52. Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment.
    Hecker M; Goertsches RH; Fatum C; Koczan D; Thiesen HJ; Guthke R; Zettl UK
    Pharmacogenomics J; 2012 Aug; 12(4):360. PubMed ID: 22825046
    [No Abstract]   [Full Text] [Related]  

  • 53. Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy.
    Carbonelli C; Montepietra S; Caruso A; Cavazza A; Feo C; Menzella F; Motti L; Zucchi L
    Monaldi Arch Chest Dis; 2012 Mar; 77(1):29-31. PubMed ID: 22662644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon beta-associated recurrence of painful trigeminal neuropathy attributed to a multiple sclerosis plaque.
    Bischof A; Sprenger T
    J Headache Pain; 2014 Apr; 15(1):21. PubMed ID: 24742132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Injection of interferon-beta in the morning decreases flu-like syndrome in many patients with multiple sclerosis.
    Nadjar Y; Coutelas E; Prouteau P; Panzer F; Paquet D; Saint-Val C; Créange A
    Clin Neurol Neurosurg; 2011 May; 113(4):316-22. PubMed ID: 21269761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Tubercular granulomas of the liver in a Somalian patient with chronic hepatitis C].
    Mulder B; van der Valk P; Hendrix R
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1091-2. PubMed ID: 11414177
    [No Abstract]   [Full Text] [Related]  

  • 57. [Guidelines of the consensus conference on multiple sclerosis].
    French Federation of Neurology, with participation of l'AEAES.
    Rev Neurol (Paris); 2001 Jul; 157(6-7):713-21. PubMed ID: 11458194
    [No Abstract]   [Full Text] [Related]  

  • 58. [Geriocaine in the treatment of multiple sclerosis].
    Gawlik L; Mazurek M; Maciejek Z; Berkan L
    Wiad Lek; 1978 May; 31(9):585-8. PubMed ID: 685274
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hypothyroidism-induced by cytokine therapy].
    Sato K
    Nihon Rinsho; 2006 May; Suppl 1():524-8. PubMed ID: 16776206
    [No Abstract]   [Full Text] [Related]  

  • 60. Suspected autoimmune hepatitis and primary biliary cirrhosis unmasked by interferon-beta in a multiple sclerosis patient.
    Kowalec K; Yoshida EM; Traboulsee A; Carleton B; Tremlett H
    Mult Scler Relat Disord; 2013 Jan; 2(1):57-9. PubMed ID: 25877455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.